CYP1B1-IN-7
CAS No. 52601-58-8
CYP1B1-IN-7( —— )
Catalog No. M37571 CAS No. 52601-58-8
CYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 235 | In Stock |
|
| 100MG | 350 | In Stock |
|
| 200MG | 516 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCYP1B1-IN-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionCYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds.
-
DescriptionCYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52601-58-8
-
Formula Weight292.76
-
Molecular FormulaC19H13ClO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C=CC1=CC=C(Cl)C=C1)C=2C=CC=3C=CC=CC3C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tyrosol
Tyrosol is a phenolic antioxidant that is naturally present in several foods such as wines and green tea and is present most abundantly in olives.
-
ε-?Viniferin
ε-Viniferin a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.
-
Ambroxol
Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
Cart
sales@molnova.com